Skip to main content
Thomas Medsger, MD, Rheumatology, Pittsburgh, PA

ThomasAMedsgerMD

Rheumatology Pittsburgh, PA

Professor, Medicine, University of Pittsburgh School of Medicine

Dr. Medsger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Medsger's full profile

Already have an account?

  • Office

    3601 5th Ave
    Falk Medical Building
    Pittsburgh, PA 15213
    Phone+1 412-647-6700

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Rheumatology, 1968 - 1969
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1965 - 1968
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemInternship, Transitional Year, 1962 - 1963
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1962

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1966 - 2018

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal Dysmotility  
    Robyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research

Press Mentions

  • My First Question Is — What Is Your Antibody Type? I Can Better Comment on the Issue of “Spontaneous Remission” Once I Know That
    My First Question Is — What Is Your Antibody Type? I Can Better Comment on the Issue of “Spontaneous Remission” Once I Know ThatJanuary 9th, 2017
  • Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)
    Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)September 19th, 2023

Grant Support

  • Relaxin In Systemic Sclerosis W/ Diffuse SclerodermaNational Center For Research Resources2000–2002
  • Double Blind Study With Oral Iloprost And Placebo In Raynaud'S PhenomenonNational Center For Research Resources1997
  • Multicenter Evaluation Of Pilocarpine HCL In Sjogrens SyndromeNational Center For Research Resources1996–1997

Professional Memberships